Satsuma Pharmaceuticals, Inc.
Underestimation
| Parameter | Grade | Value | Sector average | Difference with sector, % | Average for 5 years | Difference from average, % |
|---|---|---|---|---|---|---|
| P/E |
0/10
|
-0.53 | 35.84 | -101.47% | -3.6 | -85.33% |
| P/S |
|
0 | 127.81 | -100% |
|
|
| P/BV |
|
0.59 | 254.49 | -99.77% |
|
|
| P/FCF |
|
-0.7 | -175.22 | -99.6% |
|
|
| Ev/Ebitda |
|
-0.19 | -27.35 | -99.29% |
|
|
| Ev/S |
|
0 | 536.01 | -100% |
|
|
| Ev/FCF |
|
-0.22 | -282.71 | -99.92% |
|
|
| E/P |
|
-1.9 | 0.0223 | -8610.82% |
|
|
Efficiency
| Parameter | Grade | Value | Sector average | Difference with sector, % | Average for 5 years | Difference from average, % |
|---|---|---|---|---|---|---|
| Ebitda margin |
0/10
|
0 | -366.8 | -100% | 0 | 0% |
| ROE |
|
125.24 | 104.34 | 20.03% |
|
|
| ROA |
|
-83.95 | -2.2 | 3716% |
|
|
| ROIC |
|
0 | 1.17 | -100% |
|
|
| ROS |
|
0 | -291.82 | -100% |
|
|
| ROCE |
|
-151.5 | 3.23 | -4796.54% |
|
|
Debt
| Parameter | Grade | Value | Sector average | Difference with sector, % | Average for 5 years | Difference from average, % |
|---|---|---|---|---|---|---|
| Debt/Ebitda |
10/10
|
-0.0024 | 0.97 | -100.24% | -0.0024 | +0.0045% |
| Nеt Debt/Ebitda |
|
0.28 | 1.05 | -73.38% |
|
|
| Debt/Ratio |
|
0.0025 | 0.18 | -98.6% |
|
|
| Debt/Equity |
|
0.17 | 1.59 | -89.12% |
|
|
| Debt/Net Income |
|
-0.002 | -1.48 | -99.87% |
|
|
Dividends
| Parameter | Grade | Value | Sector average | Difference with sector, % | Average for 5 years | Difference from average, % |
|---|---|---|---|---|---|---|
| Dividend yield |
0/10
|
0 | 0.55 | -100% | 0 | 0% |
| Number of years of dividend growth |
|
0 | 0.8 | -100% | ||
| DSI |
|
0 | 0.22 | -100% |
|
|
| Average dividend growth |
|
0 | 1.88 | -100% |
|
|
| Average percentage for 5 years |
|
0 | 0.52 | -100% |
|
|
| Average percentage for payments |
|
21.68 | 59.01 | -63.26% |
|
|
| Difference from average difference in sector |
|
-0.55 |
Growth impulse
| Parameter | Grade | Value | Sector average | Difference with sector, % | ||
|---|---|---|---|---|---|---|
| Growth impulse Revenue in 5 years |
0/10
|
-35.72 | -90.69 | -60.61% | ||
| Growth impulse Ebitda in 5 years |
|
92.26 | -121.55 | -175.9% | ||
| Growth impulse Net Income in 5 years |
|
125.92 | -104.46 | -220.54% | ||
| Growth impulse FCF in 5 years |
|
62.42 | -121.68 | -151.3% | ||
| Growth impulse EPS in 5 years |
|
-60.04 | -97.03 | -38.12% |
IP Score
4.27/10
